About: Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group     Goto   Sponge   Distinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1995

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • наукова стаття, опублікована в січні 1995 (uk)
  • articolo scientifico (pubblicato il 1995) (it)
  • im Januar 1995 veröffentlichter wissenschaftlicher Artikel (de)
  • artículu científicu espublizáu en xineru de 1995 (ast)
  • artikull shkencor i botuar më 01 janar 1995 (sq)
  • scientific article published on 01 January 1995 (en)
publication date
publication date
exact match
exact match
cites work
cites work
author name string
author name string
  • W P Steward
  • P Lopez
  • M Taylor
  • G Goss
  • A Muldal
  • R Lohmann
  • G Armitage
rdfs:label
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (en)
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (nl)
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (sq)
skos:prefLabel
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (en)
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (nl)
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (sq)
name
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (en)
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (nl)
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (sq)
title
title
  • Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group (en)
page(s)
page(s)
  • 257-260
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 8729956
published in
published in
issue
volume
issue
  • 3
volume
  • 13
DOI
DOI
DOI
  • 10.1007/BF00873810
is about of
is cites work of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software